New Key Statistics Module, Z-Score and F-Score
SZSE:300238 Key Ratios
Market Cap ¥ M | 2,577.31 |
Enterprise Value ¥ M | 2,551.67 |
P/E(ttm) | 121.50 |
PE Ratio without NRI | 75.35 |
Forward PE Ratio | 31.35 |
Price/Book | 4.79 |
Price/Sales | 6.43 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 383.00 |
EPS (TTM) ¥ | 0.08 |
Beneish M-Score | -2.99 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 104.10 |
EV-to-EBITDA | 104.10 |
PEG | -- |
Shares Outstanding M | 265.16 |
Net Margin (%) | 5.33 |
Operating Margin % | 12.46 |
Pre-tax Margin (%) | 6.28 |
Quick Ratio | 1.31 |
Current Ratio | 1.79 |
ROA % (ttm) | 2.98 |
ROE % (ttm) | 3.86 |
ROIC % (ttm) | 3.19 |
Dividend Yield % | -- |
Altman Z-Score | 7.46 |
SZSE:300238 Number of Guru Trades
SZSE:300238 Volume of Guru Trades
Gurus Latest Trades with SZSE:300238
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300238 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guanhao Biotech Co Ltd Insider Transactions
No Available Data